Details for New Drug Application (NDA): 050316
✉ Email this page to a colleague
NDA 050316 describes LINCOCIN, which is a drug marketed by Pharmacia And Upjohn and Pfizer and is included in two NDAs. It is available from one supplier. Additional details are available on the LINCOCIN profile page.
The generic ingredient in LINCOCIN is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
The generic ingredient in LINCOCIN is lincomycin hydrochloride. There are eleven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the lincomycin hydrochloride profile page.
Summary for 050316
| Tradename: | LINCOCIN |
| Applicant: | Pharmacia And Upjohn |
| Ingredient: | lincomycin hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050316
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
